Log in to search using one of your social media accounts:

4 Women On What It's Really Like To Live With A Mental Illness

Opening up about struggles with mental illness can be a daunting task. Many people don’t feel comfortable doing it ― even though such illnesses are quite common.  About 1 in 5 adults in the United States experience mental illness in a given year, and 1 in 25 adults will have a debilitating mental illness that can interfere with their daily lives. Although mental illness can affect anyone, women are at a higher risk for many conditions, including anxiety and post-traumatic stress disorder. They’re also 70 percent more likely than men to experience depression. In an effort to encourage more people to share their struggles, we talked to four women about diagnosis and treatment for a variety of mental health issues. Here’s what they’ve learned along the way and what they wish others knew: Kathleen Halliday Location: Inwood, New York What condition do you have? Bipolar disorder (rapid cycling with psychotic features), generalized anxiety disorder (GAD) and an eating disorder What was your journey to diagnosis? I was always anxious as a kid. I used to tell my mom I felt bad because I didn’t know how to verbalize it. I first saw a therapist in middle school, which is where I got the GAD diagnosis. My bipolar diagnosis was rockier in that it was preceded by a manic episode. Bipolar disorder was one of my biggest fears before that, but I didn’t really think I would develop it. As for the eating disorder, I had realized I had &...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news

Related Links:

In this study we aimed to identify the thresholds for interdisciplinary collaboration amongst practitioners when treating severely depressed patients. In addition, we aimed to identify specific and feasible steps that may add to improved collaboration amongst first and second level Belgian health care providers when treating depressed patients. In two standard focus groups (n = 8; n = 12), general practitioners and psychiatrists first outlined current practice and its shortcomings. In a next phase, the same participants were gathered in nominal groups to identify and prioritise steps that could give rise to improved collab...
Source: International Journal of Integrated Care - Category: Nursing Source Type: research
Sisters Elizabeth and Melissa Ames wouldn ’t attribute their decision to embark on their entrepreneurial journey to any one particular “aha” moment. Rather, they say their idea was over a decade in the making – right from the time their late mother would tell them, “Be the change you wish to see in the world.” A special educati on teacher and district administrator, she instilled in them a deeply ingrained desire to give back and make an impact. Today, the Ames sisters’ startup, EarlyVention,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Days after Neos Therapeutics (NSDQ:NEOS) nabbed U.S. regulatory approval for its controlled-release formulation of methylphenidate, Shire (NSDQ:SHPG) said it won a nod from the FDA for its long-acting ADHD drug. The drug, Mydayis, is made up of the same active ingredient in Shire’s ADHD treatment Adderall XR – amphetamine – but it is designed to last up to 16 hours. Adderall XR is formulated to control symptoms in patients for up to 12 hours. Get the full story at our sister site, Drug Delivery Business News. The post Another extended-release ADHD drug wins FDA nod appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Food & Drug Administration (FDA) Neurological Pharmaceuticals Regulatory/Compliance Wall Street Beat neostherapeutics Shire Plc. Source Type: news
ConclusionsResults from UMBRELLA show that this novel study design is feasible and acceptable to patients in a clinical breast cancer setting. We invite researchers who are interested in conducting randomized or observational studies within the UMBRELLA cohort to contact the UMBRELLA scientific advisory board.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
ConclusionsWe confirm in this Mediterranean population the association of increasing MBD, classified according to BI-RADS with BC risk also taking into account other well-known risk factors for this neoplasm.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
A campaign to generate awareness around postpartum depression is facing criticism for its imagery. Sage Therapeutics launched “Silence Sucks” last month to encourage women to speak out about their struggles with PPD and seek treatment. The biopharmaceutical company is developing new treatment options for the disorder. While many have praised Sage Therapeutics’ efforts to help women with PPD and shatter the stigma around this topic, the “Silence Sucks” campaign has come under fire for its choice of visuals. A post shared by Sage Therapeutics (@sagebiotech) on May 7, 2017 at 4:55pm PDT Ads...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Between school and social demands, lots of children feel stress, but at what point does anxiety cross the line and become a mental health concern? Thriving sat down with Keneisha Sinclair-McBride, PhD, a clinical psychologist in the Department of Psychiatry at Boston Children’s, to better understand what separates serious forms of anxiety from normal worrying, whether seeing a therapist is warranted and how to handle anxiety at home. My child is a “worrier.” What degree of anxiety is normal and what should cause me concern? Occasional worries, like worries about the start of the school year or fitting in...
Source: Thrive, Children's Hospital Boston - Category: Pediatrics Authors: Tags: Ask the Expert Mental Health Parenting anxiety Department of Psychiatry Keneisha Sinclair-McBride worrying Source Type: news
ABC of NC, an autism services provider, will this summer begin construction of a $6.5 million expansion of its Winston-Salem campus, a move the nonprofit says will allow it to better meet the growing needs of the community. The expansion will include a new 26,000-square-foot Autism Clinic, a 3,500-square-foot activities building and renovations to its current school building. The campus is located at 905 Friedberg Church Road. A groundbreaking ceremony is slated for June 28, and the clinic should…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
Henry “Hank” Deutschendorf, one of two twins who played baby Oscar in 1989′s “Ghostbusters II,” has died. He was 28. Henry’s brother William Deutschendorf announced the tragic news via a website dedicated to raising funds to fight schizoaffective disorder, which Henry suffered from.  Henry reportedly took his own life at his home in Escondido, California, last Wednesday, according to TMZ. In 2008, he was diagnosed with schizoaffective disorder, a chronic mental health condition characterized by a combination of bipolar disorder, schizophrenia and depression.  “H...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
While most patients with panic disorder respond to selective serotonin reuptake inhibitors, benzodiazepines, and/or a combination of the two, the risk of relapse after drug discontinuation is known to be high. Astudy in theJournal of Clinical Psychopharmacology now suggests that patients who take clonazepam may be at a lower risk of relapse than those treated with paroxetine.The findings were based on an observational, prospective, six-year follow-up study of patients with panic disorder who participated in anopen, randomized trial in which they were assigned to take either clonazepam (0.5 mg/d to 2 mg/d) or paro...
Source: Psychiatr News - Category: Psychiatry Tags: anxiety disorders benzodiazepines clonazepam Journal of Clinical Psychopharmacology panic disorder paroxetine Rafael C. Freire SSRIs taper treatment discontinuation Source Type: research
More News: ADHD | Anorexia | Anxiety | Autism | Bipolar | Brain | Cardiology | Chemistry | Depression | Eating Disorders & Weight Management | Generalized Anxiety Disorder (GAD) | Heart | Hormone Replacement Therapy | Hormones | Hypothyroidism | Internet | Mania | Men | Neurology | Nutrition | Panic Disorder | Post Traumatic Stress Disorder | Psychology | Sexual Abuse | Sports Medicine | Websites | Women | Zoloft